Clinical Trial

Cerebral Small Vessel Disease Progression Dependent on Stroke Type

Study acronym: ZMA_BIO
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this prospective, observational study is to understand if cerebral small vessel disease (CSVD) has different velocities and patterns of temporal development, dependent on a concurrent ischemic stroke. It focusses on adult patients with known or newly diagnosed CSVD on magnetic resonance imaging. The study will evaluate if blood based, in parts central nervous system specific protein markers, so called biomarkers, have an additional value reflecting the course of CSVD as defined per MRI assessments. Further patient-relevant endpoints include neuropsychological abilities, neurological functional outcomes, quality of life assessments, stroke recurrence risk.
Trial Details
NCT Number NCT07611136
Lead Sponsor Johannes Dorst
Conditions Cerebral Small Vessel Disease, Stroke, Stroke Recurrence, Biomarkers
Enrollment 180 participants
Start Date 2026-03-26
Primary Completion 2028-04-01 (estimated)
Study Completion 2028-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-28